These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35982512)

  • 1. TOPICAL CARBONIC ANHYDRASE INHIBITORS IN THE LONG-TERM TREATMENT OF JUVENILE X-LINKED RETINOSCHISIS.
    Schmitt MA; Wang K; DeBenedictis MJ; Traboulsi EI
    Retina; 2022 Nov; 42(11):2176-2183. PubMed ID: 35982512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Carbonic Anhydrase Inhibitors on Cystoid Fluid Collections and Visual Acuity in Patients with X-Linked Retinoschisis.
    Hensman J; Hahn LC; van Schooneveld MJ; Diederen RMH; Ten Brink JB; Florijn RJ; Bergen AA; Strubbe I; Heutinck P; van Genderen MM; van den Born LI; Thiadens AA; de Zaeytijd J; Leroy BP; Hoyng CB; Boon CJF
    Ophthalmol Retina; 2024 Jun; 8(6):600-606. PubMed ID: 38104928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis.
    Genead MA; Fishman GA; Walia S
    Arch Ophthalmol; 2010 Feb; 128(2):190-7. PubMed ID: 20142541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of dorzolamide for patients with X-linked retinoschisis.
    Apushkin MA; Fishman GA
    Retina; 2006 Sep; 26(7):741-5. PubMed ID: 16963845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USE OF A CARBONIC ANHYDRASE INHIBITOR IN X-LINKED RETINOSCHISIS: Effect on Cystic-Appearing Macular Lesions and Visual Acuity.
    Andreuzzi P; Fishman GA; Anderson RJ
    Retina; 2017 Aug; 37(8):1555-1561. PubMed ID: 27828908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of optic disc pit-associated macular retinoschisis after topical carbonic anhydrase inhibitor treatment: Report of a case.
    Al-Moujahed A; Callaway NF; Vail D; Ludwig CA; Ji MH; Moshfeghi DM
    Eur J Ophthalmol; 2021 May; 31(3):NP25-NP28. PubMed ID: 32019335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-linked Juvenile Retinoschisis in a Young Female.
    Ranabhat S; Byanju R; Khadka S
    J Nepal Health Res Counc; 2022 Jun; 20(1):260-264. PubMed ID: 35945887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STELLATE NONHEREDITARY IDIOPATHIC FOVEOMACULAR RETINOSCHISIS: RESPONSE TO TOPICAL DORZOLAMIDE THERAPY.
    Ajlan RS; Hammamji KS
    Retin Cases Brief Rep; 2019; 13(4):364-366. PubMed ID: 28557864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dramatic regression of macular and peripheral retinoschisis with dorzolamide 2 % in X-linked retinoschisis: a case report.
    Sadaka A; Sisk RA
    J Med Case Rep; 2016 Jun; 10(1):142. PubMed ID: 27246168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase inhibitors limit complications in X-linked retinoschisis.
    Wey S; Brill DA; Miraldi Utz V; Sisk RA
    Front Med (Lausanne); 2023; 10():1281068. PubMed ID: 38020097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of response to treatment with dorzolamide in X-linked retinoschisis to the mechanism of functional loss in retinoschisin.
    Walia S; Fishman GA; Molday RS; Dyka FM; Kumar NM; Ehlinger MA; Stone EM
    Am J Ophthalmol; 2009 Jan; 147(1):111-115.e1. PubMed ID: 18834580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diurnal variations of foveoschisis by optical coherence tomography in patients with RS1 X-linked juvenile retinoschisis.
    Abalem MF; Musch DC; Birch DG; Pennesi ME; Heckenlively JR; Jayasundera T
    Ophthalmic Genet; 2018 Aug; 39(4):437-442. PubMed ID: 29902095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical Anatomic Response to Topical Carbonic Anhydrase Inhibitor in X-linked Retinoschisis.
    Menke B; Walters A; Payne JF
    Ophthalmic Surg Lasers Imaging Retina; 2018 Feb; 49(2):142-144. PubMed ID: 29443366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic Anhydrase Inhibitors for the Treatment of Cystic Macular Lesions in Children With X-Linked Juvenile Retinoschisis.
    Verbakel SK; van de Ven JP; Le Blanc LM; Groenewoud JM; de Jong EK; Klevering BJ; Hoyng CB
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5143-5147. PubMed ID: 27699410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of topical and systemic carbonic anhydrase in the treatment of chromosome X-linked retinoschisis.
    Rocha Cabrera P; Pareja Ríos AC; Cordovés Dorta L; Mantolán Sarmiento C; Serrano García MA
    Arch Soc Esp Oftalmol; 2014 Aug; 89(8):320-3. PubMed ID: 24269421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked retinoschisis maculopathy treated with topical dorzolamide, and relationship to genotype.
    Khandhadia S; Trump D; Menon G; Lotery AJ
    Eye (Lond); 2011 Jul; 25(7):922-8. PubMed ID: 21527955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-linked juvenile retinoschisis in females and response to carbonic anhydrase inhibitors: case report and review of the literature.
    Ali S; Seth R
    Semin Ophthalmol; 2013 Jan; 28(1):50-4. PubMed ID: 23163265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cystic cavities in X-linked juvenile retinoschisis: The first sequential cross-over treatment regimen with dorzolamide.
    Coussa RG; Kapusta MA
    Am J Ophthalmol Case Rep; 2017 Dec; 8():1-3. PubMed ID: 29260104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of topical dorzolamide for patients with X-linked juvenile retinoschisis: case report.
    Bastos AL; Freitas Bde P; Villas Boas O; Ramiro AC
    Arq Bras Oftalmol; 2008; 71(2):286-90. PubMed ID: 18516436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase inhibitors in patients with X-linked retinoschisis: effects on macular morphology and function.
    Testa F; Di Iorio V; Gallo B; Marchese M; Nesti A; De Rosa G; Melillo P; Simonelli F
    Ophthalmic Genet; 2019 Jun; 40(3):207-212. PubMed ID: 31149861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.